[1] |
Dispenzieri A. How I treat POEMS syndrome [J]. Blood, 2012, 119(24): 5650-5658.
|
[2] |
Dispenzieri A, Armitage JO, Loe MJ, et al. The clinical spectrum of Castleman′s disease [J]. Am J Hematol, 2012, 87(11): 997-1002.
|
[3] |
Dispenzieri A. POEMS syndrome [J]. Blood Rev, 2007, 21(6): 285-299.
|
[4] |
Dispenzieri A. POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management [J]. Am J Hematol, 2011, 86(7): 591-601.
|
[5] |
Xu D, Lv J, Dong Y, et al. Renal involvement in a large cohort of Chinese patients with Castleman disease [J]. Nephrol Dial Transplant, 2012, 27(Suppl 3): iii119-125.
|
[6] |
Lee JP, Kim DK, Oh DY, et al. Successfully treated multicentric Castleman′s disease with renal thrombotic microangiopathy using rituximab and corticosteroid [J]. Clin Nephrol, 2011, 75(2): 165-170.
|
[7] |
Fujiwara H, Mise N, Ishimoto Y, et al. Case of mesangial proliferative glomerulonephritis complicated with multicentric Castleman′s disease [J]. Nihon Jinzo Gakkai Shi, 2011, 53(2): 189-194.
|
[8] |
Yuan XG, Hu W, Chen FF, et al. Renal complications of Castleman′s disease: report of two cases and analysis of 75 cases [J]. Clin Exp Nephrol, 2011, 15(6): 921-926.
|
[9] |
Nagai K, Usui J, Noguchi K, et al. A case of multicentric Castleman′s disease with membranoproliferative glomerulonephritis type 3-like lesion [J]. Pathol Int, 2011, 61(11): 686-690.
|
[10] |
Caro-Cuenca MT, Ortega-Salas R, Espinosa-Hernandez M. Renal AA amyloidosis in a Castleman′s disease patient [J]. Nefrologia, 2012, 32(5): 699-700.
|
[11] |
Zhang H, Wang R, Wang H, et al. Membranoproliferative glomerulonephritis in Castleman′s disease: a systematic review of the literature and 2 case reports [J]. Intern Med, 2012, 51(12): 1537-1542.
|
[12] |
Sui Y, Zhao D. Report of six kidney disease-associated Castleman′s disease cases [J]. Clin Nephrol, 2015, 84(6): 344-352.
|
[13] |
王素霞, 邹古明, 章友康, 等.Castleman病肾损害的临床病理分析 [J]. 中华肾脏病杂志, 2009, 25(8): 585-590.
|
[14] |
王洁. 以新月体肾炎为表现的Castleman病2例分析并文献复习 [J]. 右江民族医学院学报, 2010, 32(3): 326-328.
|
[15] |
黄婵桃, 黄信华, 贾铭, 等.纵隔Castleman病合并肾病综合征一例 [J]. 放射学实践, 2007, 22(3): 317-318.
|
[16] |
王秀芬, 张丽红, 张艳玲, 等.多中心浆细胞型淋巴结增生症并发间质性肾炎一例 [J]. 中华肾脏病杂志, 2009, 25(6): 457.
|
[17] |
占永立, 张改华, 王丽, 等.Castleman病继发新月体性肾炎1例 [J]. 中国中西医结合肾病杂志, 2007, 8(3): 173-174.
|
[18] |
邹古明, 陈文, 谌贻璞, 等.Castleman病继发肾淀粉样变性一例报告及文献复习 [J]. 中华肾脏病杂志, 2007, 23(5): 308-311.
|
[19] |
王洁.表现为内皮细胞病的Castleman病临床分析 [J]. 右江医学, 2010, 38(3): 279-280.
|
[20] |
赵新菊, 韦洮, 甘良英, 等.合并肾损害的POEMS综合征患者的临床及预后分析 [J]. 北京医学, 2014, 36(2): 96-101.
|
[21] |
隋燕霞, 王鸿雁, 杨喆, 等.Castleman病合并肾脏损害5例临床病理学分析 [J]. 临床与实验病理学杂志, 2013, 29(8): 859-862.
|
[22] |
魏立新, 邹和群, 李中和, 等.Castleman病并肾病综合征1例 [J]. 中国中西医结合肾病杂志, 2005, 6(4): 199-199.
|
[23] |
方一卿, 殷家珍, 程晓霞, 等.表现为毛细血管内增生性肾炎的Castleman病一例 [J]. 中华肾脏病杂志, 2011, 27(4): 310-310.
|
[24] |
江蓓, 杨向东, 宋强, 等.以肾损害为首发表现的Castleman病误诊1例分析并文献复习 [J]. 中国误诊学杂志, 2007, 7(25): 5967-5969.
|
[25] |
杨光, 刘佳, 邢昌赢, 等. Castleman病并发膜性肾病一例 [J]. 中华肾脏病杂志, 2011, 27(7): 550.
|
[26] |
袁博寒, 王宇晖, 余瑾, 等.Castleman病合并肾损害3例 [J]. 浙江实用医学, 2014, 19(4): 294-296.
|
[27] |
叶琨, 龚智峰, 彭小梅, 等.Castleman病继发间质性肾炎1例 [J]. 临床荟萃, 2009, 24(20): 1783-1790.
|
[28] |
张育安, 罗长青, 朱红艳, 等.POEMS综合征并TMA样肾损害一例 [J]. 临床肾脏病杂志, 2013(3): F0003.
|
[29] |
章正华, 龙志国, 张建鄂.以肾损害为首发表现的Castleman病一例 [J]. 中华肾脏病杂志, 2005, 21(1): 25.
|
[30] |
芦建华, 史晓虎, 杨冠男, 等. Castleman病导致亚急性肾小管间质损害1例报告 [J]. 中华老年多器官疾病杂志, 2010, 9(1): 83-88.
|
[31] |
杨林, 张丽萍, 李绍梅.膜性肾病合并抗基底膜性肾小球肾炎及Castleman病1例 [J]. 临床荟萃, 2010, 25(18): 1645-1646.
|
[32] |
Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: Definitions and long-term outcome [J]. Blood, 2003, 101(7): 2496-2506.
|
[33] |
Bitter MA, Komaiko W, Franklin WA. Giant lymph node hyperplasia with osteoblastic bone lesions and the POEMS (Takatsuki′s) syndrome [J]. Cancer, 1985, 56(1): 188-194.
|
[34] |
Ye W, Wang C, Cai QQ, et al. Renal impairment in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes syndrome: incidence, treatment and outcome [J]. Nephrol Dialysis Transplant, 2016, 31(2): 275-283.
|
[35] |
Dispenzieri A. POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management [J]. Am J Hematol, 2014, 89(2): 214-223.
|
[36] |
Ji ZF, Zhang DY, Weng SQ, et al. POEMS Syndrome: A Report of 14 Cases and Review of the Literature [J]. ISRN Gastroenterol, 2012, 2012: 584287.
|
[37] |
Soubrier M, Sauron C, Souweine B, et al. Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndrome [J]. Am J Kidney Dis, 1999, 34(4): 633-638.
|
[38] |
Fukatsu A, Ito Y, Yuzawa Y, et al. A case of POEMS syndrome showing elevated serum interleukin 6 and abnormal expression of interleukin 6 in the kidney [J]. Nephron, 1992, 62(1): 47-51.
|
[39] |
Mizuiri S, Mitsuo K, Sakai K, et al. Renal involvement in POEMS syndrome [J]. Nephron, 1991, 59(1): 153-156.
|
[40] |
Nakamoto Y, Imai H, Yasuda T, et al. A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome [J]. Nephrol Dial Transplant, 1999, 14(10): 2370-2378.
|
[41] |
Navis GJ, Dullaart RP, Vellenga E, et al, Renal disease in POEMS syndrome: report on a case and review of the literature [J]. Nephrol Dial Transplant, 1994, 9(10): 1477-1481.
|
[42] |
Zhang L, Li Z, Cao X, et al. Clinical spectrum and survival analysis of 145 cases of HIV-negative Castleman′s disease: renal function is an important prognostic factor [J]. Sci Rep, 2016, 6: 23831.
|
[43] |
Kojima M, Nakamura N, Tsukamoto N, et al. Clinical implications of idiopathic multicentric castleman disease among Japanese: a report of 28 cases [J]. Int J Surg Pathol, 2008, 16(4): 391-398.
|
[44] |
Frizzera G, Peterson BA, Bayrd ED, et al. A systemic lymphoproliferative disorder with morphologic features of Castleman′s disease: clinical findings and clinicopathologic correlations in 15 patients [J]. J Clin Oncol, 1985, 3(9): 1202-1216.
|
[45] |
El Karoui K, Vuiblet V, Dion D, et al. Renal involvement in Castleman disease [J]. Nephrol Dial Transplant, 2011, 26(2): 599-609.
|